<PAGE>
As filed with the Securities and Exchange Commission on July 7, 1999
Registration No. 333-69945
================================================================================
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
_________________
AMENDMENT NO. 3
TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
_________________
ENVIROGEN, INC.
(Exact Name of Registrant as Specified in Its Charter)
_________________
<TABLE>
<S> <C>
Delaware 22-2899415
(State of Incorporation) (I.R.S. Employer Identification Number)
Robert S. Hillas, President
4100 Quakerbridge Road Envirogen, Inc.
Lawrenceville, New Jersey 08648 4100 Quakerbridge Road
(609) 936-9300 Lawrenceville, New Jersey 08648
(609) 936-9300
(Address, Including Zip Code, and Telephone Number, Including (Name, Address, Including Zip Code, and Telephone Number, Including
Area Code, of Registrant's Principal Executive Offices) Area Code, of Agent for Service)
</TABLE>
_______________________
Copy to:
John E. Stoddard III, Esq.
Drinker Biddle & Reath LLP
105 College Road East
Princeton, NJ 08542-0627
(609) 716-6504
Approximate date of commencement of proposed sale to the public: From time
to time after the effective date of this Registration Statement as determined by
market conditions and other factors.
If the only securities being registered on this form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. [_]
If any of the securities being registered on this form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. [X]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. [_]
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [_]
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [_]
_______________________
The registrant hereby amends this Registration Statement on such date or
dates as may be necessary to delay its effective date until the registrant shall
file a further amendment which specifically states that this Registration
Statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of 1933 or until the Registration Statement shall become
effective on such date as the Commission, acting pursuant to said Section 8(a),
may determine.
================================================================================
<PAGE>
The information in this prospectus is not complete and may be changed.We may not
sell these securities until the registration statement filed with the Securities
and Exchange Commission is effective. This prospectus is not an offer to sell
these securities and it is not soliciting an offer to buy these securities in
any state where the offer or sale is not permitted.
SUBJECT TO COMPLETION, DATED JULY 7, 1999
PROSPECTUS ENVIROGEN, INC.
83,334 SHARES 4100 Quakerbridge Road
COMMON STOCK Lawrenceville, N.J. 08648
(609) 936-9300
www.envirogen.com
Robert S. Hillas, currently the Chairman, President and Chief Executive
Officer and a director of Envirogen, Inc., is offering and selling 83,334 shares
of Envirogen common stock under this prospectus. Envirogen will not receive any
of the proceeds from the sale of the shares offered hereby, but will pay for all
expenses of this offering, other than commissions or discounts of broker-
dealers.
Envirogen's common stock is currently traded on the Nasdaq SmallCap Market
under the symbol "ENVG." The closing price of Envirogen's common stock on the
Nasdaq SmallCap Market on June 30, 1999 was $1.3125 per share.
---------------
These securities involve a high degree of risk. See "Risk Factors"
beginning on page 2 of this prospectus.
---------------
Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or determined if this
prospectus is truthful or complete. Any representation to the contrary is a
criminal offense.
---------------
The date of this prospectus is July __, 1999.
<PAGE>
ABOUT ENVIROGEN
Envirogen is an environmental services and systems company combining unique
scientific, engineering and management expertise to provide innovative solutions
for treating hazardous wastes in soil, water and air. Envirogen's strategic
approach for systems development includes isolating natural organisms, in some
cases enhancing their performance through genetic modification, and then
developing engineered systems to optimize their activity for biodegradation.
Envirogen offers solutions for both pollution prevention and remediation
problems of business entities and government agencies and offers a broad range
of specialized environmental consulting services and systems, including remedial
investigation, design and construction and engineering and compliance
management.
RISK FACTORS
You should carefully consider the following factors and other information
in this prospectus before deciding to invest in the shares of Envirogen common
stock. Some of the statements contained in this prospectus and in the documents
incorporated by reference in this prospectus are forward-looking. Actual results
may differ materially from those suggested by the forward-looking statements for
various reasons, including those discussed in the following risk factors.
Envirogen has a history of operating losses and no assurance of
profitability. Envirogen has never made a profit on an annual basis, has only
recently begun to receive revenues from the use or sale of its systems that
biologically degrade hazardous waste and had an accumulated deficit of
$51,859,256 at March 31, 1999. Envirogen expects to spend additional funds for
the continued development of its degradation systems and the commercialization
of its technologies. Envirogen cannot guaranty that it will generate sufficient
revenues to achieve profitability.
Additional changes under PECFA program may further reduce Envirogen's
revenue. The State of Wisconsin, which reimburses certain eligible environmental
cleanup costs of Envirogen's customers under the Wisconsin Petroleum
Environmental Cleanup Fund Act ("PECFA"), may in the future adopt additional
regulatory rules, or eliminate the PECFA program in its entirety, resulting in
reductions in Envirogen's revenue, net income and cash flow. In April 1998,
Wisconsin adopted PECFA emergency rules that reduced the amount of funds
available for reimbursement under the PECFA program and dramatically reduced
Envirogen's revenue, net income and cash flow. As a result of that event,
Envirogen recorded a non-cash charge of $21,670,028 in the second quarter of
1998 representing the impairment of goodwill associated with Envirogen's
acquisition of Fluid Management Inc.
Envirogen's reserve for ineligible PECFA claims may be inadequate. There
can be no assurance that Envirogen's reserve for ineligible PECFA claims is
adequate or that Envirogen will not be required to make additional adjustments
to such reserve in the future. Following an analysis by Envirogen of trends
indicating an increase in the PECFA claims that were being declared ineligible
for reimbursement, Envirogen recorded a charge of $1,650,000 during the fourth
quarter of 1998 to increase the reserve for ineligible PECFA claims.
-2-
<PAGE>
Envirogen may need additional financing. Envirogen may require additional
funds to develop and commercialize certain of its technologies. Envirogen has
funded its operations to date primarily through revenues from commercial
operations, research grants from government agencies, research and development
agreements with major industrial companies and public offerings and private
placements of equity securities. However, Envirogen may not be successful in
raising additional funds or, if successful, the terms of such funding may not be
advantageous to Envirogen and its stockholders at that time.
Easing of environmental regulation could adversely affect Envirogen's
business. Envirogen's business is substantially dependent upon federal, state
and local laws and regulations that require companies to make expenditures to
meet minimum environmental standards for air, water and soil quality and impose
significant penalties for noncompliance. If the scope or enforcement of such
laws and regulations is eased, there would be less demand for Envirogen's
systems and services which would likely have a material adverse effect on
Envirogen's business.
Envirogen competitors may develop superior technologies to treat and
remediate wastes. Envirogen's processes or systems may become less competitive
or obsolete as a result of the development by others of technologies similar or
superior to those of Envirogen. Envirogen currently encounters intense
competition from other environmental treatment companies, as well as from
engineering and waste management service companies, universities, research
institutions and others. Such competition may increase as advances in the
treatment and remediation of wastes are made. Many of Envirogen's competitors
have substantially greater financial and marketing resources and capabilities
than Envirogen. In addition, some competitors, particularly waste management
service companies, may be able to offer a more complete solution to a client's
environmental problems than Envirogen will be able to offer.
Envirogen may not be able to obtain patents or utilize certain technologies
that are patented by or proprietary to Envirogen's competitors. Certain
competitors of Envirogen have been issued patents or have filed applications for
patents or have proprietary rights to microorganisms, systems or processes
competitive with those of Envirogen. If patents or proprietary technology rights
are obtained by competitors, Envirogen may not be permitted to use certain of
its microorganisms, systems or processes which could materially adversely affect
Envirogen's financial condition and results of operations. Envirogen may seek
patent protection for unique microorganisms (including genetically-modified
forms) or for novel processes which it develops that degrade hazardous wastes.
However, Envirogen does not believe that patents are critical to the successful
development of marketable systems. In general, due to the newness and complexity
of the science involved in biotechnology, the application of the patent laws to
this field is presently unclear. Envirogen cannot guaranty that its pending
patent applications will be granted or, if granted, that their claims will be
sustained if challenged.
Certain agreements may restrict Envirogen's use of technology developed
with others. Envirogen cannot predict the extent to which future research and
development agreements may impose restrictions on Envirogen's ability to utilize
any technology developed under a particular agreement or require Envirogen to
pay royalties on the use of such technology. Envirogen's research and
development agreements to date have not placed significant restrictions on
Envirogen's use of the technology developed under such agreements. In certain
cases, the agreements provide for a sharing of rights to the technology which is
jointly developed by
-3-
<PAGE>
Envirogen and the other party to the agreement, and/or the payment by Envirogen
of limited royalties on the use of technology developed solely by the other
party or developed jointly.
Envirogen's license of its technology to another party may reduce or
eliminate the scope of services that Envirogen might otherwise render to that
party. Certain of Envirogen's research and development agreements grant to the
other party a non-exclusive license to utilize technology developed under the
agreement for its own facilities but not for other purposes, such as
commercialization through third parties. In those cases, the scope of services
Envirogen might otherwise render to such party as a potential customer may be
reduced or eliminated.
Envirogen may not be able to license other's technology. Envirogen may seek
licenses to other parties' technology in order to develop, manufacture and
market certain technologies in the future. However, Envirogen may not be able to
obtain necessary licenses or such licenses may not be available on commercially
acceptable terms. Even if such licenses are available, the patents or
proprietary rights underlying the licenses may prove to be invalid or
unenforceable.
Envirogen cannot be assured of additional funding from corporate and
governmental relationships. Envirogen has relied and will continue to rely on
contracts with corporate and governmental sponsors to fund a significant portion
of its research and development activities. During 1998, Envirogen recorded
approximately $2,572,000 of revenue from corporate and governmental sponsored
research and development agreements and grants. Envirogen cannot guaranty that
additional funding from new research and development agreements and grants will
be available at levels or on terms that it deems satisfactory. The elimination
or significant reduction in additional funding from new research and development
agreements and grants could narrow the scope of Envirogen's long-term research
and development efforts.
Envirogen's common stock cannot be assured of continued listing on Nasdaq.
Under current Nasdaq rules, if the price of Envirogen common stock falls below
$1.00 per share for 30 consecutive trading days, shares of Envirogen common
stock will be subject to possible delisting by Nasdaq. The likely effects of
Nasdaq delisting would include the following:
. The common stock would be quoted in the "pink sheets" maintained by the
National Quotation Bureau, Inc.
. The spread between the bid and the ask price of the common stock would
be greater than at present.
. Stockholders may experience a greater degree of difficulty in engaging
in trades of shares of the common stock.
. Envirogen would incur additional costs in connection with any Nasdaq
relisting application and would be required to satisfy initial listing
requirements that are more stringent than the continued listing
requirements that Envirogen must currently satisfy.
. Broker-dealers would be required to make additional disclosures in
connection with effecting transactions in Envirogen common stock, which
could severely limit the market liquidity of the common stock and the
ability of investors to trade shares of the common stock.
-4-
<PAGE>
From November 24, 1998, which is the date Envirogen effected a one-for-six
reverse split of its common stock to raise the per share price of its common
stock to at least $1.00, through the date of this prospectus, the closing price
per share of Envirogen common stock has been between $1.00 and $2.25. Envirogen
cannot guaranty that the price of its common stock will remain above $1.00 per
share, that if it falls below $1.00 Envirogen's stockholders will again approve
a reverse split of common stock to increase the per share price, or that
Envirogen will be able to satisfy the other Nasdaq continued listing
requirements.
Envirogen is subject to costly and time consuming regulatory requirements.
Various federal, state and local agencies generally regulate the technologies
under development by Envirogen. Such regulation applies to all stages of field
testing and to the manufacture and use of certain of Envirogen's technologies.
Prior to the manufacture and use of certain of its technologies, Envirogen will
be required to conduct extensive toxicology and environmental testing to
demonstrate its safety. This regulatory process could be costly and time
consuming and could delay or prevent research, development, production or
marketing of such technologies. If it fails to comply with this regulatory
process, Envirogen could face material fines or penalties or injunctive relief
which could materially adversely affect its business. Furthermore, special
interest groups may object to the release of Envirogen's microorganisms into the
environment and deter governmental agencies from granting the requisite
approvals on a timely basis or at all, or otherwise adversely affect Envirogen's
ability to field test and market its products.
Envirogen is controlled by its officers and directors and their affiliates.
At December 31, 1998, Envirogen's executive officers and directors and their
affiliates owned approximately 48% of the outstanding shares of Envirogen's
common stock and, accordingly, may have the ability to control Envirogen and all
issues submitted to Envirogen's stockholders.
Envirogen has limited insurance coverage for environmental and product
liability risks. Third parties may assert product liability and environmental
impairment claims against Envirogen with respect to the testing or use of
Envirogen's technologies. Envirogen cannot guaranty that such environmental or
product liability claims will be covered by its $5,000,000 contractor's
pollution and product liability insurance policy, that the dollar amount of
covered liabilities will not exceed policy limits or that such insurance will
continue to be available to Envirogen on commercially acceptable terms, or at
all. An uninsured or partially covered judgment against Envirogen could have a
materially adverse effect on Envirogen. Envirogen will attempt to mitigate some
of the uninsured risks by typically not transporting or taking title to its
customers' waste, although such measures are not sufficient to avoid all
potential liability.
Possible acquisitions of related businesses or technologies by Envirogen
may involve difficult operational integration issues and could decrease existing
stockholders' percentage ownership. Envirogen from time to time evaluates and
investigates possible purchase, license or other acquisitions of related
businesses or technologies. Such acquisitions have certain risks, including,
among others, incorrectly assessing the asset quality and the extent of possible
liabilities of a particular business being acquired and encountering greater
than anticipated costs of incorporating acquired businesses into Envirogen. In
addition, in the event that Envirogen uses its common stock as consideration for
acquisitions or to obtain licenses of new technologies, the percentage ownership
of Envirogen's stockholders immediately prior to such transaction will decrease.
-5-
<PAGE>
Envirogen's stock price has been volatile and could continue to fluctuate
substantially. The market price of Envirogen's common stock has been volatile
and could continue to fluctuate substantially. The market price of Envirogen's
common stock may be significantly impacted by many factors, including, among
others, announcements, by Envirogen or its competitors, of technical
developments, establishment of corporate relationships, governmental regulation,
patent or proprietary rights, developments or public concern as to safety or
other implications of the biodegradation of hazardous wastes and general market
conditions.
Envirogen has not paid any common stock dividends. Envirogen has not paid
any cash dividends on its common stock since its inception and does not
anticipate paying any cash dividends on its common stock in the foreseeable
future.
Uncertainty regarding state of year 2000 readiness of third parties with
whom Envirogen has a material relationship. As of the date of this prospectus,
Envirogen is in the process of upgrading its information systems and software so
that such systems and software will function properly with respect to dates in
the year 2000. To date, Envirogen has not incurred any material costs in
connection with its year 2000 issues and does not anticipate that future
expenditures will have a material impact on its financial position or operating
results. However, Envirogen has not completed its assessment of all of its
material vendors, customers, banks and other third parties regarding their year
2000 compliance, including corporate and governmental sponsors that fund a
significant portion of Envirogen's research and development activities.
Envirogen's or any material third party's failure to correct a year 2000 problem
could result in an interruption or failure in Envirogen's operations, which
could adversely affect Envirogen's results of operations, cash flows or
financial conditions. At this time, Envirogen has not completed its development
of a comprehensive contingency plan to deal with any such interruptions or
failures.
-6-
<PAGE>
WHERE YOU MAY FIND ADDITIONAL INFORMATION
Envirogen files annual, quarterly and special reports, proxy statements and
other information with the SEC. You may read and copy any document we file at
the SEC's public reference rooms at 450 Fifth Street, N.W., Washington, D.C.
20549, at Seven World Trade Center, Suite 1300, New York, New York 10048 or at
Citicorp Center, 500 West Madison Street, Suite 1400, Chicago, Illinois 60661.
You may obtain information on the operation of the public reference rooms by
calling the SEC at 1-800-SEC-0330. Envirogen's SEC filings are also available to
the public from the SEC's website at http://www.sec.gov. Envirogen's common
stock is quoted on the Nasdaq Smallcap Market, and reports and other information
concerning Envirogen may be inspected at the National Association of Securities
Dealers, Inc. at 1735 K Street, N.W., Washington, D.C. 20006-1500.
The SEC allows us to "incorporate by reference" the information we file
with them, which means that we can disclose important information to you by
referring you to those documents. The information incorporated by reference is
considered to be part of this prospectus, and information that we file later
with the SEC will automatically update and supersede this information. We
incorporate by reference the documents listed on the following page and any
future filings we will make with the SEC under Sections 13(a), 13(c), 14 or
15(d) of the Securities Exchange Act of 1934 until the selling stockholder sells
all of the shares of Envirogen common stock offered pursuant to this prospectus.
(a) Envirogen's Annual Report on Form 10-K for the year ended December 31,
1998;
(b) Envirogen's Current Report on Form 8-K dated March 31, 1999, as
amended by Envirogen's Current Report on Form 8-K/A dated March 31, 1999 and
filed with the SEC on April 12, 1999;
(c) Envirogen's Quarterly Report on Form 10-Q for the quarter ended March
31, 1999; and
(d) The description of Envirogen's common stock contained in the
registration statement (File No. 0-20404) filed by Envirogen to register such
securities under the Securities Exchange Act of 1934, including all amendments
and reports filed to update such description.
You may request a copy of these filings, at no cost, by writing or
telephoning us at the following address: Investor Relations, Envirogen, Inc.,
4100 Quakerbridge Road, Lawrenceville, New Jersey 08648; telephone (609) 936-
9300.
This prospectus is part of a registration statement we filed with the SEC.
You should rely only on the information incorporated by reference or provided in
this prospectus or any supplement to this prospectus. We have not authorized
anyone else to provide you with different information. The selling stockholder
will not make an offer of these shares of Envirogen common stock in any state
where the offer is not permitted. You should not assume that the information in
this prospectus or any supplement to this prospectus is accurate as of any date
other than the date on the front of those documents.
-7-
<PAGE>
USE OF PROCEEDS
Envirogen will not receive any of the proceeds from the sale of the shares
of Envirogen common stock offered hereby, but will pay for all expenses of this
offering, other than commissions or discounts of broker-dealers. Such expenses
are estimated to be approximately $30,000.
SELLING STOCKHOLDER
Robert S. Hillas, currently the Chairman, President and Chief Executive
Officer and a director of Envirogen, is the selling stockholder. As of the date
of this prospectus, Mr. Hillas beneficially owned 132,422 outstanding shares of
Envirogen common stock, 83,334 shares of which are being offered for sale by
this prospectus. After the sale of all of the shares of Envirogen common stock
being offered for sale by this prospectus, Mr. Hillas will beneficially own
49,088 outstanding shares of Envirogen common stock.
PLAN OF DISTRIBUTION
Robert S. Hillas, currently the Chairman, President and Chief Executive
Officer and a director of Envirogen, is the selling stockholder. The selling
stockholder may offer his shares of Envirogen common stock at various times in
one or more public or private transactions on or off the Nasdaq SmallCap Market.
He may sell at market prices prevailing at the time of sale, at prices related
to such prevailing market prices, at negotiated prices or at fixed prices. In
addition, the shares may be sold, to the extent permitted, from time to time in
transactions effected in accordance with Rule 144 under the Securities Act of
1933. This prospectus may be used by pledgees, donees, transferees or other
successors in interest to the selling stockholder to offer and sell the shares
of Envirogen common stock, provided that this prospectus has been supplemented
appropriately to disclose the name and the number of shares beneficially owned
by such person.
Various state securities laws and regulations require that the sale of the
shares of Envirogen common stock under this prospectus be made only through the
use of a broker-dealer registered in any state where the selling stockholder
engages such broker-dealer and in any state where such broker-dealer intends to
offer and sell the shares. The selling stockholder may use broker-dealers to
sell his shares of Envirogen common stock in such states or in any other state,
in which case the broker-dealers will either receive discounts, commissions or
concessions on such sales from the selling stockholder or from purchasers of
such shares for whom they acted as agents. Any discounts, commissions or
concessions received by any such broker-dealer and any profits on the sale of
shares by them may be deemed to be underwriting discounts and commissions under
the Securities Act of 1933.
Under the Securities Exchange Act of 1934, any person engaged in a
distribution of the shares offered under this prospectus may not bid for or
purchase the shares until after such person has completed his participation in
such distribution, including the period of five business days prior to the
commencement of such distribution. In addition, the selling stockholder and any
other person participating in such distribution will be subject to other
applicable provisions of the Securities Exchange Act of 1934, including
Regulation M, which provisions may affect the timing of purchases and sales of
any of the shares by the selling stockholder and any such other person. All of
the foregoing may affect the marketability of the shares and the ability of any
person or entity to engage in market-making activities with respect to the
shares.
-8-
<PAGE>
LEGAL MATTERS
Drinker Biddle & Reath LLP, Philadelphia, Pennsylvania, counsel for
Envirogen, will issue a legal opinion addressing the validity of the securities
offered in this prospectus. Morgan R. Jones, a partner in Drinker Biddle & Reath
LLP, is the Secretary of Envirogen.
EXPERTS
The consolidated balance sheets as of December 31, 1998 and 1997 and the
consolidated statements of operations, changes in stockholders' equity and cash
flows of Envirogen, Inc. for each of the three years in the period ended
December 31, 1998, incorporated by reference in this prospectus, have been
incorporated herein in reliance on the report of PricewaterhouseCoopers LLP,
independent accountants, given on the authority of that firm as experts in
accounting and auditing.
-9-
<PAGE>
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 14. Other Expenses of Issuance and Distribution.
The following table sets forth the estimated expenses payable by the
registrant in connection with this Registration Statement.
<TABLE>
<CAPTION>
<S> <C>
Securities and Exchange Commission Registration Fee...................................................$ 25.35
Accounting Fees and Expenses.......................................................................... 15,000.00
Legal Fees and Expenses............................................................................... 10,000.00
Miscellaneous Expenses................................................................................ 4,974.65
------------
Total................................................................................................$ 30,000.00
============
</TABLE>
Item 16. Exhibits.
Exhibit
Number Description
------ -----------
23 Consent of PricewaterhouseCoopers LLP
II-1
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this Amendment No. 3 to
Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized in the City of Lawrenceville, State of New Jersey, on July 7,
1999.
ENVIROGEN, INC.
By: /s/ Robert S. Hillas
--------------------------------
Robert S. Hillas, President
Pursuant to the requirements of the Securities Act of 1933, this Amendment
No. 3 to Registration Statement has been signed by the following persons, in the
capacities indicated, on July 7, 1999.
<TABLE>
<CAPTION>
Signature Title
- --------- -----
<S> <C>
/s/Robert S. Hillas Chairman of the Board, President, Chief
- ---------------------------------- Executive Officer and Director
Robert S. Hillas (Principal Executive Officer)
/s/Mark J. Maten Vice President of Finance and Chief
- ---------------------------------- Financial Officer (Principal Financial
Mark J. Maten and Accounting Officer)
Robert F. Hendrickson* Director
- ----------------------------------
Robert F. Hendrickson
Robert F. Johnston* Director
- ----------------------------------
Robert F. Johnston
Nicholas J. Lowcock* Director
- ----------------------------------
Nicholas J. Lowcock
Robert C. Miller* Director
- ----------------------------------
Robert C. Miller
Peter J. Neff* Director
- ----------------------------------
Peter J. Neff
William C. Smith* Director
- ----------------------------------
William C. Smith
</TABLE>
_________________________
*Robert S. Hillas, pursuant to a Power of Attorney executed by each of the
directors noted above and filed with the Securities and Exchange Commission as
Exhibit 24 to this Registration Statement on Form S-3, by signing his name
hereto, does hereby sign and execute this Amendment No. 3 to Registration
Statement on behalf of each of the persons noted above, in the capacities
indicated.
/s/Robert S. Hillas
-------------------------------------
Robert S. Hillas
II-2
<PAGE>
EXHIBIT INDEX
-------------
Exhibit
Number Description
- ------ -----------
23 Consent of PricewaterhouseCoopers LLP
<PAGE>
Exhibit 23
----------
CONSENT OF INDEPENDENT ACCOUNTANTS
----------------------------------
We hereby consent to the incorporation by reference in this Registration
Statement on Form S-3 of our report dated February 17, 1999 relating to the
consolidated financial statements and financial statement schedule of Envirogen,
Inc., which appears in Envirogen, Inc.'s Annual Report on Form 10-K for the year
ended December 31, 1998. We also consent to the reference to us under the
heading "Experts" in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Florham Park, New Jersey
July 6, 1999
